| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▼ | 1.05▼ | 1.05▼ | 1.10▼ | 1.14▼ |
| MA10 | 1.05▼ | 1.05▼ | 1.05▼ | 1.12▼ | 1.15▼ |
| MA20 | 1.05▼ | 1.05▼ | 1.07▼ | 1.16▼ | 1.22▼ |
| MA50 | 1.05▼ | 1.09▼ | 1.12▼ | 1.20▼ | 2.43▼ |
| MA100 | 1.05▼ | 1.12▼ | 1.16▼ | 1.25▼ | 3.48▼ |
| MA200 | 1.08▼ | 1.17▼ | 1.12▼ | 2.25▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.003▲ | 0.001▲ | -0.012▼ | 0.070▲ |
| RSI | 43.204▼ | 42.836▼ | 38.094▼ | 39.872▼ | 36.707▼ |
| STOCH | 23.333 | 69.583 | 57.946 | 35.548 | 19.608▼ |
| WILL %R | -100.000▼ | -50.000 | -68.750 | -84.848▼ | -88.742▼ |
| CCI | -84.187 | -20.452 | -61.765 | -160.633▼ | -85.678 |
| ▼ GAP | $ZURA Open Gap Down %2 | Set Alert |
|
Tuesday, July 01, 2025 04:44 AM
Zura Bio (NASDAQ:ZURA) has announced the appointment of Eric Hyllengren as CFO, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as ...
|
|
Tuesday, July 01, 2025 03:30 AM
Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/07/25 | 1.02 | 1.07 | 1.00 | 1.05 | 585,200 |
| 30/06/25 | 1.13 | 1.13 | 1.04 | 1.05 | 361,500 |
| 27/06/25 | 1.175 | 1.175 | 1.025 | 1.05 | 5,600,277 |
| 26/06/25 | 1.17 | 1.20 | 1.115 | 1.15 | 242,900 |
| 25/06/25 | 1.22 | 1.22 | 1.15 | 1.18 | 171,700 |
| 24/06/25 | 1.13 | 1.21 | 1.10 | 1.21 | 500,300 |
| 23/06/25 | 1.12 | 1.16 | 1.10 | 1.12 | 328,500 |
| 20/06/25 | 1.11 | 1.20 | 1.11 | 1.13 | 536,800 |
| 18/06/25 | 1.13 | 1.1499 | 1.10 | 1.11 | 308,949 |
| 17/06/25 | 1.19 | 1.20 | 1.14 | 1.14 | 297,719 |
|
|
||||
|
|
||||
|
|